Viewing Study NCT02814058


Ignite Creation Date: 2025-12-25 @ 12:15 AM
Ignite Modification Date: 2026-02-24 @ 1:15 AM
Study NCT ID: NCT02814058
Status: COMPLETED
Last Update Posted: 2018-06-08
First Post: 2016-06-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 1.75 mg Formulation
Sponsor: Biolab Sanus Farmaceutica
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None pharmacokinetics View
None Healthy Volunteers View